Opus Genetics, Inc.
For the period ended Sep 30, 2025. Filed Nov 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 12, 2025
IRD$4.18+4.4%Stored close · as of Nov 6, 2026
Contents
Item 1. Financial Statements
| Item 1. | Financial Statements |
|---|
Condensed Consolidated Balance Sheets
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.